偏头痛治疗:迈向新的药理目标
Marcello Silvestro1,2, Luigi Francesco Iannone3, Ilaria Orologio1
1Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
International journal of molecular sciences
|August 12, 2023
概括
偏头痛治疗正在发展,超出了色素基因相关 (CGRP) 的目标. 新的研究探索了其他途径,如PACAP,VIP和TRP道,以更好地预防偏头痛.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的偏头痛预防疗法往往有偏离目标的效果和低患者坚持.
- 素基因相关 (CGRP) 途径以单克隆抗体和 gepants 为目标,彻底改变了偏头痛预防.
- 很大一部分患者对当前的CGRP向疗法仍有不充分的反应.
研究的目的:
- 审查涉及偏头痛病理生理学的新兴和替代途径.
- 突出未来偏头痛预防治疗的潜在新目标.
- 巩固这些新目标的临床前和临床证据.
主要方法:
- 临床前和临床研究的文献综述.
- 对挑性研究进行分析,确定主要的偏头痛途径.
- 关于神经,受体和细胞内通路的证据综合.
主要成果:
- 鉴定了CGRP家族成员 (上腺素,氨酸),秘密家族成员 (PACAP,VIP),TRP通道,通道,阿片类系统和纯能通路可能与偏头痛有关.
- 这些途径在不同偏头痛患者中表现出不同程度的参与.
- 有证据表明,这些途径是预防偏头痛的可行目标.
结论:
- 除了CGRP,其他几个分子通路在偏头痛病理生理学中至关重要.
- 针对这些新的途径,包括PACAP,VIP和TRP道,为开发更有效的偏头痛预防治疗提供了有希望的途径.
- 通过考虑这些途径在个体患者中的不同作用,可以制定个性化治疗策略.
相关概念视频
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Antidepressant Drugs: MAOIs and Other Agents
274
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
274
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K


